DS003 is a potent antiretroviral entry inhibitor molecule being developed by the International Partnership for Microbicides (IPM) as a vaginal microbicide candidate. With the ultimate goal of developing a combination microbicide vaginal ring containing DS003 and dapivirine, this study evaluated the potential for incorporation of high loadings of DS003 in ethylene vinyl acetate (EVA) matrix-type rings suitable for testing in macaques.
|Publication status||Published - 1 Oct 2016|
|Event||2nd HIV Research for Prevention Conference - Chicago, United States|
Duration: 17 Oct 2016 → 21 Oct 2016
|Conference||2nd HIV Research for Prevention Conference|
|Period||17/10/16 → 21/10/16|